COVID News from biospace.com Novavax Hit Hard by Late Vaccine, while BioNTech Touts Variant-Adapted Shots biospace.com STR/NurPhoto via Getty Images On Monday, vaccine-focused biopharma company Novavax released its second quarter financial results, showing a dramatic adjustment...
